Delivery Order SPE2DB22D2007-SPE2DB25FJ4GD
- Not listed
- The Defense Logistics Agency awarded a $27,497.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,712.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $30,288.15 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $45,468.54 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,438.95 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,910.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $11,725.57 and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.32 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4GDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,399.90 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This firm fixed-price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive, non-set-aside procurement. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen continues to support the Defense Health Agency and broader military healthcare systems through its extensive pharmaceutical supply network. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Ozempic, a diabetes medication included within the company's extensive portfolio of brand-name pharmaceuticals, represents one of numerous critical medications supplied through this flexible contract vehicle to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/22/25 |